DEEJ(SZ:000423)2022-12-03 09:11Group 1: Company Development Strategy - The company's "13th Five-Year" strategy focuses on the core business of Ejiao, cultivating multiple brands, and promoting cultural marketing and value return projects [1] - The strategy aims to enhance the comprehensive value through live donkey resource development and extend upstream and downstream in the industry chain [1] - The company positions Ejiao as a "national treasure for nourishment," targeting high-end consumers and developing products like compound Ejiao syrup for broad consumption [3] Group 2: Sales Performance - The company is currently operating stably and believes the Ejiao market will continue to develop positively, allowing more consumers to experience the benefits of Ejiao products [3] - E-commerce sales currently account for a small proportion, with younger consumers being the primary demographic, although online consumption among middle-aged and elderly consumers is gradually increasing [3] Group 3: Shareholding and Governance - China Resources Pharmaceutical has increased its shareholding to over 30%, reflecting confidence in the company's future development and recognition of its value [3] Group 4: Supply Chain and Pricing - The supply of donkey hides includes a certain proportion from abroad, with differences in scale and systematic breeding compared to domestic practices [4] - The company adjusts product prices based on supply and demand changes, determined by market development conditions [4] Group 5: Future Product Development - The company plans to strengthen upstream resource control and implement cultural and academic marketing, focusing on clinical validation of Ejiao products [4] - There are ongoing developments in derivative products, such as Ejiao oatmeal juice, with expectations for growth [4] Group 6: Regional Sales Focus - The company aims to develop and expand in key regions such as the Yangtze River Delta and the Pearl River Delta, where competition is relatively intense [4]